Endovia Health Sciences EDVA Estimates

NYSE EDVA
$0.17 -0.01 (-7.93%)
As of: Sep 29, 2026 · 3:58 PM EDT
Analyst Estimates

Endovia Health Sciences, Inc. Revenue Estimates

Periods 14
Next Period Q4 24
Consensus 1.74 M

Analysts expect Endovia Health Sciences, Inc. to report revenue of 1.74 M for Q4 24, against a range of 1.60 M to 1.89 M. The most recent reported quarter, Q3 25, came in at 393,072.00, a 90.1% miss against the 3.98 M consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 1.05 M981,860.00-68,606.00-393,072.00------
High Estimate 1.72 M2.33 M1.89 M3.35 M3.06 M4.33 M4.27 M4.36 M5.68 M4.78 M6.96 M7.51 M
Low Estimate 1.57 M2.07 M1.60 M2.76 M2.60 M3.63 M3.94 M3.67 M4.73 M4.46 M6.05 M6.29 M
Consensus Estimate 1.64 M2.20 M1.74 M3.05 M2.83 M3.98 M4.11 M4.01 M5.20 M4.62 M6.51 M6.90 M
Analyst Estimates

Endovia Health Sciences, Inc. Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q4 24
Consensus -12.02

Analysts expect Endovia Health Sciences, Inc. to report earnings per share of -12.02 for Q4 24, against a range of -12.95 to -11.09. The most recent reported quarter, Q2 26, came in at -0.66, a 94.7% beat against the -12.28 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -17.60-12.80--7.86-17.61-18.04-2.20-0.66------
High Estimate -13.19-11.05-11.09-11.52-11.38-10.93-12.34-11.05-11.63-11.33-11.38-11.27-11.66-10.60
Low Estimate -14.73-13.47-12.95-13.28-13.30-12.97-14.26-13.51-13.33-13.09-12.60-12.25-12.44-12.80
Consensus Estimate -13.96-12.26-12.02-12.40-12.34-11.95-13.30-12.28-12.48-12.21-11.99-11.76-12.05-11.70

Endovia Health Sciences, Inc. Estimates API

Pull Wall Street consensus for Endovia Health Sciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=EDVA&mode=revenue&api_key=YOUR_API_KEY